Patient Square Bets Big on NKTR: A Deep Dive for Investors
A prominent investor placed a sizable stake in Nektar Therapeutics, sparking questions about the stock's potential. T...
This intro covers where to store your emergency fund in 2026, highlighting high-yield accounts, liquidity, and risk considerations to help you decide.
24,678 articlesA prominent investor placed a sizable stake in Nektar Therapeutics, sparking questions about the stock's potential. T...
A fresh retirement-income blueprint uses a $1 million portfolio anchored by SCHD to target roughly $58,000 per year i...
Public space stocks are quietly expanding the orbital economy ahead of SpaceX's IPO. This report surveys Rocket Lab, ...
Interest in Rocket Lab stock is rising as the small-launch market tightens. This guide breaks down why everyone is ta...
A 10% move in Vericel stock drew attention after a COO sold shares worth $402,000. This article breaks down what the ...
A growing share of older investors are moving away from high-yield bond funds toward short-term Treasury ETFs in sear...
Six days after listing, a buyer snaps $4.8 million for a Medina luxury home next to Bill Gates’ Xanadu 2.0, underscor...
Two small modular reactor players, NuScale Power and Oklo, are reshaping how utilities think about clean energy. This...
As the world leans harder on reliable, low-emission power, these nuclear energy stocks could offer compelling opportu...
The Russell 2000 has climbed roughly 31% over the past year, signaling a shift toward small-cap leadership. Two stock...
Nu Holdings has fallen about 31% from its peak this year. This article breaks down the business, the pullbacks, and w...
Tech stocks retreat sparked a broader market pause, but analysts insist the stock market isn’t crashing — it’s a rota...